Trial · NCT03461146
Results by group25
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 25
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Hb Level of Week 20 and Week 24 | MT-6548 | 10.75 | 95% Confidence Interval 10.35 to 11.14 | g/dL | |
| Hb Level at Each Assessment Time Point | MT-6548 | Baseline | 9.15 | 95% Confidence Interval 8.73 to 9.57 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 2 | 9.25 | 95% Confidence Interval 8.83 to 9.68 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 4 | 9.53 | 95% Confidence Interval 9.03 to 10.04 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 6 | 9.90 | 95% Confidence Interval 9.37 to 10.43 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 8 | 10.33 | 95% Confidence Interval 9.80 to 10.85 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 10 | 10.56 | 95% Confidence Interval 10.08 to 11.04 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 12 | 10.68 | 95% Confidence Interval 10.18 to 11.19 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 16 | 11.17 | 95% Confidence Interval 10.66 to 11.68 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 20 | 11.08 | 95% Confidence Interval 10.73 to 11.43 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 24 | 11.03 | 95% Confidence Interval 10.60 to 11.45 | g/dL |
| Hb Level at Each Assessment Time Point | MT-6548 | Week 24 (LOCF) | 10.56 | 95% Confidence Interval 9.95 to 11.17 | g/dL |
| Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment Period | MT-6548 | Baseline | 16.7 | percentage of subjects | |
| Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment Period | MT-6548 | Week 2 | 21.7 | percentage of subjects | |
| Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment Period | MT-6548 | Week 4 | 36.4 | percentage of subjects | |
| Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment Period | MT-6548 | Week 6 | 47.6 | percentage of subjects | |
| Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment Period | MT-6548 | Week 8 | 55.0 | percentage of subjects | |
| Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment Period | MT-6548 | Week 10 | 63.2 | percentage of subjects | |
| Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment Period | MT-6548 | Week 12 | 68.4 | percentage of subjects | |
| Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment Period | MT-6548 | Week 16 | 63.2 | percentage of subjects |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03461146/results